G. Feichter

420 total citations
27 papers, 277 citations indexed

About

G. Feichter is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, G. Feichter has authored 27 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Reproductive Medicine. Recurrent topics in G. Feichter's work include Ovarian cancer diagnosis and treatment (6 papers), Cancer Genomics and Diagnostics (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). G. Feichter is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Cancer Genomics and Diagnostics (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). G. Feichter collaborates with scholars based in Germany, Switzerland and United States. G. Feichter's co-authors include Peter Dalquen, Dirk Heberling, H. Schmid, M. Kaufmann, W Kühn, F Gudat, Guido Sauter, J. Torhorst, Ulrich Abel and Ursula Dürmüller and has published in prestigious journals such as Gynecologic Oncology, International Journal of Oncology and Acta Oto-Laryngologica.

In The Last Decade

G. Feichter

27 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Feichter Germany 9 99 85 75 63 52 27 277
M. Kiechle‐Schwarz Germany 12 81 0.8× 57 0.7× 97 1.3× 74 1.2× 54 1.0× 23 319
P. G. Knapstein Germany 10 82 0.8× 43 0.5× 139 1.9× 59 0.9× 73 1.4× 24 339
Christian Lussier Canada 10 65 0.7× 48 0.6× 122 1.6× 58 0.9× 96 1.8× 16 408
Antoni Pessarrodona Spain 12 207 2.1× 144 1.7× 124 1.7× 36 0.6× 99 1.9× 27 430
Alba Mota Spain 9 104 1.1× 40 0.5× 52 0.7× 42 0.7× 31 0.6× 13 364
Terri Woo United States 7 85 0.9× 36 0.4× 129 1.7× 35 0.6× 114 2.2× 8 394
Kaj Bjelkenkrantz Sweden 14 115 1.2× 55 0.6× 120 1.6× 11 0.2× 116 2.2× 24 403
T S Frank United States 7 146 1.5× 187 2.2× 111 1.5× 121 1.9× 67 1.3× 8 602
Susan Valmadre Australia 7 70 0.7× 25 0.3× 108 1.4× 102 1.6× 69 1.3× 11 319
Josefine Stani Austria 8 52 0.5× 40 0.5× 162 2.2× 19 0.3× 42 0.8× 12 352

Countries citing papers authored by G. Feichter

Since Specialization
Citations

This map shows the geographic impact of G. Feichter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Feichter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Feichter more than expected).

Fields of papers citing papers by G. Feichter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Feichter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Feichter. The network helps show where G. Feichter may publish in the future.

Co-authorship network of co-authors of G. Feichter

This figure shows the co-authorship network connecting the top 25 collaborators of G. Feichter. A scholar is included among the top collaborators of G. Feichter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Feichter. G. Feichter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feichter, G., et al.. (2012). Diagnose und Graduierung zervikaler intraepithelialer Neoplasien. Der Pathologe. 33(2). 118–123. 2 indexed citations
2.
Kocjan, Gabrijela, G. Feichter, B Hagmar, et al.. (2006). Fine needle aspiration cytology: a survey of current European practice. Cytopathology. 17(5). 219–226. 22 indexed citations
3.
Vögelin, Esther, G. Feichter, & N J Lüscher. (1997). Breast cancer in previously burned skin: a postburn skin adnexal malignancy?. Burns. 23(4). 366–368. 4 indexed citations
4.
Feichter, G., et al.. (1997). Breast Cytology. Acta Cytologica. 41(2). 327–332. 44 indexed citations
5.
Dellas, Athanassios, Holger Moch, Elisabeth Schultheiss, et al.. (1997). Association of tumor induced vascularization with clinicopathological parameters in cervical neoplasm. International Journal of Oncology. 11(1). 105–9. 3 indexed citations
6.
Feichter, G., et al.. (1995). Malignant melanoma of the uterine cervix; case report including cytology, histology and immunocytochemistry.. PubMed. 6(3). 196–200. 8 indexed citations
7.
Minckwitz, G von, W Kühn, M. Kaufmann, et al.. (1994). Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer. International Journal of Gynecological Cancer. 4(4). 250–256. 7 indexed citations
8.
Dalquen, Peter, et al.. (1993). Immunocytochemistry in Diagnostic Cytology. Recent results in cancer research. 133. 47–80. 12 indexed citations
9.
Feichter, G., et al.. (1993). Sarkome der Mamma: Was bringen Immunhistochemie und Flowzytometrie?. Geburtshilfe und Frauenheilkunde. 53(11). 811–813. 5 indexed citations
10.
Moch, Holger, J. Torhorst, Ursula Dürmüller, et al.. (1993). Comparative Analysis of the Expression of Tenascin and Established Prognostic Factors in Human Breast Cancer. Pathology - Research and Practice. 189(5). 510–514. 33 indexed citations
11.
Feichter, G., et al.. (1990). Zur Dignität von Psammomkarzinomen des Ovars - eine klinische, DNA-durchflußzytophotometrische und morphometrisch-bildanalytische Studie. Geburtshilfe und Frauenheilkunde. 50(8). 597–604. 4 indexed citations
12.
Kühn, W., et al.. (1989). Prognostische Bedeutung zellkinetischer Parameter beim Endometriumkarzinom. Geburtshilfe und Frauenheilkunde. 49(9). 787–792. 1 indexed citations
13.
Kühn, W, et al.. (1989). DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors. Gynecologic Oncology. 33(3). 360–367. 44 indexed citations
14.
Oberholzer, M., G. Feichter, Peter Dalquen, et al.. (1989). A Simple “Expert System” for Morphometric Evaluation of Cells in Pleural Effusions. Pathology - Research and Practice. 185(5). 647–651. 3 indexed citations
15.
Steven, F.S., et al.. (1989). A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.. PubMed. 8(6). 1179–83. 5 indexed citations
16.
Feichter, G., et al.. (1988). Flow-zytophotometrische Parameter, Hormonrezeptoren und axillärer Lymphknotenstatus als Prognosefaktoren beim primären Mammakarzinom. Geburtshilfe und Frauenheilkunde. 48(10). 705–709. 4 indexed citations
17.
Feichter, G., et al.. (1988). New Frontiers in Cytology : Modern Aspects of Research and Practice. Medical Entomology and Zoology. 3 indexed citations
18.
Feichter, G., H. Maier, D. Adler, et al.. (1987). S-phase fractions and DNA-ploidy of oropharyngeal squamous epithelium carcinomas compared with histologic grade, stage, response to chemotherapy and survival. Acta Oto-Laryngologica. 104(3-4). 377–384. 29 indexed citations
19.
Kühn, W, et al.. (1987). Morphologische Prognosekriterien und klinischer Verlauf bei Ovarialtumoren vom »Borderline-Typ«. Geburtshilfe und Frauenheilkunde. 47(3). 173–178. 3 indexed citations
20.
Tauber, P. F., et al.. (1977). Lokale Proteinase-Inhibitor-Konzentration im uterinen Sekret bei Intrauterinspiralen (IUD) in situ. Archives of Gynecology and Obstetrics. 224(1-4). 32–33. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026